A new approach to imaging analytics driven by machine learning algorithms can identify metastasized breast cancer with sensitivity rates that exceed other automated methods and even rival human...
GRAIL, Inc., a precision medicine and life sciences company aiming to develop new very early detection techniques for cancer, has attracted more than $900 million in investment capital from some of the...
Providers who combined genetic testing with a clinical decision support tool to treat home health patients using multiple medications were able to reduce hospital readmissions by 52 percent and cut ED...
An international academic research consortium will use precision medicine strategies and a new $21 million grant from the National Institutes of Health to further research into the development and...
Investigators at the Dana-Farber/Boston Children's Cancer and Blood Disorders Center found that precision medicine can be used to diagnose genetic abnormalities and properly treat patients with...
Northwell Health and Indivumed are creating a new patient biobank to help expand opportunities for cancer research and the development of precision medicine therapies.
In the three-year agreement...
The American Association for Cancer Research (AACR) is releasing more than 19,000 de-identified genomic records to further the international research community’s explorations into precision...
The calendar year may be coming to its end, but the nation’s work on precision medicine is just getting started. Spurred on by the continuing development of big data analytics techniques and...
The Penn Center for Precision Medicine (PCMP) Accelerator Fund has divided $525,000 between eight promising personalized medicine projects addressing topics such as neurodegenerative diseases, infection...
The FDA is ready and willing to get started on the precision medicine and drug innovation opportunities created by the 21st Century Cures Act, FDA Commissioner Robert M. Califf, MD, said in a blog...
The Translational Genomics Research Institute (TGen) and the independent City of Hope cancer and diabetes center have announced a new research alliance aimed at accelerating the development of...
Lawmakers anticipating a tough landscape for innovation funding under a new Republican administration are doing their best to push a revamped version of the 21st Century Cures Act through the current...
Personalization isn’t just for online advertisements and shopping suggestions. It is becoming a primary driver of healthcare innovations, too.
From tailored therapies based on...
The United States healthcare system still has a long way to go before it develops the seamless health data interoperability required to take on the most pressing precision medicine challenges, including...
Precision medicine partnerships are becoming all the rage as public and private healthcare organizations pool their expertise and resources to overcome the challenges of developing personalized...
Skyrocketing drug prices, insufficient healthcare data transparency, and slugglish precision medicine innovation cycles are placing a significant strain on Medicare patients, many of whom are unable to...
Precision medicine projects, partnerships, and collaborations are continuing to proliferate as providers, research organizations, and vendors look to capitalize on the growing enthusiasm for integrating...
Genomic testing is becoming an increasingly common starting place for the development of personalized medicine treatments for patients with a variety of hard-to-treat diseases, especially cancer, but...
The FDA and the European Medicines Agency (EMA) are working together to advance precision medicine treatments for patients with rare diseases, officials announced last week, marking more than a decade...
The pediatric cancer death rate declined by 20 percent between 1999 and 2014, according to new data from the National Center for Health Statistics (NCHS), indicating that precision medicine techniques...
